330 related articles for article (PubMed ID: 18243519)
21. Endocrine actions of cortistatin: in vivo studies.
Broglio F; Grottoli S; Arvat E; Ghigo E
Mol Cell Endocrinol; 2008 May; 286(1-2):123-7. PubMed ID: 18281148
[TBL] [Abstract][Full Text] [Related]
22. Identification and pharmacological characterization of somatostatin receptors in rat lung.
Schloos J; Raulf F; Hoyer D; Bruns C
Br J Pharmacol; 1997 Jul; 121(5):963-71. PubMed ID: 9222554
[TBL] [Abstract][Full Text] [Related]
23. Proadrenomedullin N-terminal peptide and cortistatin activation of MrgX2 receptor is based on a common structural motif.
Nothacker HP; Wang Z; Zeng H; Mahata SK; O'Connor DT; Civelli O
Eur J Pharmacol; 2005 Sep; 519(1-2):191-3. PubMed ID: 16111673
[TBL] [Abstract][Full Text] [Related]
24. Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors.
Cervia D; Langenegger D; Schuepbach E; Cammalleri M; Schoeffter P; Schmid HA; Bagnoli P; Hoyer D
Neuropharmacology; 2005 May; 48(6):881-93. PubMed ID: 15829258
[TBL] [Abstract][Full Text] [Related]
25. Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor.
Feuerbach D; Fehlmann D; Nunn C; Siehler S; Langenegger D; Bouhelal R; Seuwen K; Hoyer D
Neuropharmacology; 2000 Jun; 39(8):1451-62. PubMed ID: 10818261
[TBL] [Abstract][Full Text] [Related]
26. Cortistatin: a natural somatostatin analog.
de Lecea L
J Endocrinol Invest; 2005; 28(11 Suppl International):10-4. PubMed ID: 16625839
[TBL] [Abstract][Full Text] [Related]
27. Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides.
Kamohara M; Matsuo A; Takasaki J; Kohda M; Matsumoto M; Matsumoto S; Soga T; Hiyama H; Kobori M; Katou M
Biochem Biophys Res Commun; 2005 May; 330(4):1146-52. PubMed ID: 15823563
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.
Ferone D; Boschetti M; Resmini E; Giusti M; Albanese V; Goglia U; Albertelli M; Vera L; Bianchi F; Minuto F
Ann N Y Acad Sci; 2006 Jun; 1069():129-44. PubMed ID: 16855140
[TBL] [Abstract][Full Text] [Related]
29. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland.
Deghenghi R; Papotti M; Ghigo E; Muccioli G
J Endocrinol Invest; 2001 Jan; 24(1):RC1-3. PubMed ID: 11227737
[TBL] [Abstract][Full Text] [Related]
30. Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides.
Rivier JE; Kirby DA; Erchegyi J; Waser B; Eltschinger V; Cescato R; Reubi JC
J Med Chem; 2005 Jan; 48(2):515-22. PubMed ID: 15658865
[TBL] [Abstract][Full Text] [Related]
31. Null mutant mouse models of somatostatin and cortistatin, and their receptors.
Zeyda T; Hochgeschwender U
Mol Cell Endocrinol; 2008 May; 286(1-2):18-25. PubMed ID: 18206294
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility.
Annunziata M; Luque RM; Durán-Prado M; Baragli A; Grande C; Volante M; Gahete MD; Deltetto F; Camanni M; Ghigo E; Castaño JP; Granata R
Hum Reprod; 2012 Jul; 27(7):2117-29. PubMed ID: 22588000
[TBL] [Abstract][Full Text] [Related]
33. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.
Broglio F; Koetsveld Pv Pv; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Gauna C; Hofland L; Deghenghi R; Arvat E; Van Der Lely AJ; Ghigo E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4829-32. PubMed ID: 12364482
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features.
Siehler S; Zupanc GK; Seuwen K; Hoyer D
Neuropharmacology; 1999 Mar; 38(3):449-62. PubMed ID: 10219983
[TBL] [Abstract][Full Text] [Related]
35. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
[TBL] [Abstract][Full Text] [Related]
36. Somatostatin receptors.
Raynor K; Reisine T
Crit Rev Neurobiol; 1992; 6(4):273-89. PubMed ID: 1358464
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin, Alzheimer's disease and cognition: an old story coming of age?
Epelbaum J; Guillou JL; Gastambide F; Hoyer D; Duron E; Viollet C
Prog Neurobiol; 2009 Oct; 89(2):153-61. PubMed ID: 19595735
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity.
Siehler S; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):510-21. PubMed ID: 10598790
[TBL] [Abstract][Full Text] [Related]
39. Characterization and distribution of somatostatin binding sites in goldfish brain.
Cardenas R; Lin X; Chavez M; Aramburo C; Peter RE
Gen Comp Endocrinol; 2000 Jan; 117(1):117-28. PubMed ID: 10620428
[TBL] [Abstract][Full Text] [Related]
40. Somatostatin family of peptides and its receptors in fish.
Lin X; Otto CJ; Cardenas R; Peter RE
Can J Physiol Pharmacol; 2000 Dec; 78(12):1053-66. PubMed ID: 11149381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
